3 results
Post-market clinical follow-up of a magnetic bone conduction implant (Cochlear Baha® Attract System)
This post-market clinical follow-up investigation aims to evaluate the usability and the mid- to long-term performance of the Baha Attract System in terms of hearing outcomes and safety. The objective is to compare the hearing performance with the…
We aim to establish proof-of-concept for use of pembrolizumab as novel neo-adjuvant therapy in dMMR and POLE-EDM UC. When ICB proves to be feasible as defined in the primary endpoint (see 2.1), we will follow-up with larger studies to determine…
Primary Objective:* To evaluate the effect of every-other-week subcutaneous (SC) administration of XmAb5871 on the time to IgG4-related disease (IgG4-RD) disease flare following an initial course of corticosteroid therapy in subjects with active…